908 Devices Inc (MASS) — Titan Protect Analysis

MASS

908 Devices Inc

Healthcare · ·

$7.93

Data: 2026-06-03

✓ ETHICAL PASS

NONE MOAT

LIMITED

Data Confidence: 0.0%

Key Metrics

How this company measures up on the fundamentals that matter

Market Cap

$330M

Total market value of the company

Trailing P/E

N/A

Forward P/E

-30.49

Based on estimated future earnings — lower means cheaper

Rev Growth

+13.6%

Year-over-year revenue change

Profit Margin

-62.4%

How much profit the company keeps from each dollar of revenue

ROE

-24.1%

Return on equity — how efficiently it uses shareholder money

Analyst Target

$11.00

+39% from current price — median analyst estimate

Recommendation

NONE

Consensus view from 2 analysts covering this stock

About 908 Devices Inc

908 Devices Inc. provides purpose-built handheld mass spectrometry and fourier transform infrared (FTIR) devices for use in vital health and safety applications. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; XplorIR, a handheld device that uses FTIR spectroscopy to identify, quantify, and track gases and vapors; ThreatID, a portable FTIR device that ra

https://908devices.com

Country: United States Employees: 172 Industry: Medical Devices

Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity

PASS

Core business does not involve prohibited activities

Debt Ratio

0.0% PENDING

Debt must be below 33% of total assets

Cash Ratio

0.0% PENDING

Interest-bearing cash below 33% of assets

Receivables

0.0% PENDING

Receivables below 49% of assets

Revenue Purity

0.0% PENDING

Non-compliant revenue below 5% — any excess requires purification

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime

MARKUP

Price trending up with increasing momentum

Sharpe Ratio

0.615

Good returns relative to risk taken

Kelly Fraction

0.0405

Modest edge detected — smaller position warranted

Calmar Ratio

0.271

Drawdown risk outweighs the returns — higher risk profile

Annual Return

18.9%

Historical annualised return based on price data

Max Drawdown

-69.9%

Largest peak-to-trough decline — the worst it has been

HMM State

BEAR

Statistical model detects bearish conditions

Days in State

246

How long the current regime has persisted — longer means more stable

Market Data

Trading characteristics and market positioning

Beta

0.57

Less volatile than the market — more defensive

52W High

$9.34

15% below the year high

52W Low

$5.03

58% above the year low

Avg Volume

276,642

Average daily shares traded — higher means easier to buy and sell

Short Ratio

12.3

Days it would take all short sellers to cover — higher means more crowded

Short % Float

N/A

Div Yield

N/A

Annual dividend as a percentage of the share price

EPS (TTM)

$-0.97

Earnings per share over the last 12 months

Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity

3.33

Heavy leverage — higher financial risk if revenues decline

Current Ratio

N/A

Quick Ratio

N/A

Like current ratio but excludes inventory — stricter test

Gross Margin

52.0%

Revenue left after cost of goods — higher means pricing power

Operating Margin

-48.6%

Profit from core operations before interest and tax

Free Cash Flow

$14M

Positive — the business generates more cash than it spends

Revenue (TTM)

$58M

Total revenue over the last 12 months

Net Income

$-35,395,000

Loss-making — spending exceeds revenue after all costs

Analyst Coverage

Analysts

Target High

$12.00

Target Median

$11.00

Target Low

$10.00

Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-06-03

Before you go